市場調査レポート
商品コード
1386357
肺炎球菌ワクチン市場レポート:2030年までの動向、予測、競合分析Pneumococcal Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
肺炎球菌ワクチン市場レポート:2030年までの動向、予測、競合分析 |
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
|
肺炎球菌ワクチンの動向と予測
世界の肺炎球菌ワクチン市場は、2024年から2030年までのCAGRが4.8%で、2030年までに推定112億4,000万米ドルに達すると予想されます。この市場の主な促進要因は、肺炎球菌ワクチン接種の重要性に対する意識の高まり、新しく革新的な肺炎球菌ワクチンの開拓、肺炎球菌ワクチン接種を促進する政府の取り組みです。世界の肺炎球菌ワクチン市場の将来性は、肺炎球菌結合型ワクチンと肺炎球菌多糖体ワクチン市場にチャンスがあることから有望視されています。
肺炎球菌ワクチン市場の洞察
prevnar13は、肺炎球菌の13の血清型によって引き起こされる肺炎球菌性疾患から小児と成人を守ることができるため、予測期間中に最も高い成長が見込まれるとLucintelは予測しています。
この市場の中で、肺炎球菌結合型ワクチンは、小児や若年成人の肺炎球菌性疾患を予防する能力があるため、予測期間中に高い成長が見込まれます。
Pneumococcal Vaccine Trends and Forecast
The future of the global pneumococcal vaccine market looks promising with opportunities in the pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine markets. The global pneumococcal vaccine market is expected to reach an estimated $11.24 billion by 2030 with a CAGR of 4.8% from 2024 to 2030. The major drivers for this market are growing awareness of the importance of pneumococcal vaccination, development of new and innovative pneumococcal vaccines, and government initiatives to promote pneumococcal vaccination.
A more than 150-page report is developed to help in your business decisions.
Pneumococcal Vaccine by Segment
The study includes a forecast for the global pneumococcal vaccine by product type, vaccine type, and region.
Pneumococcal Vaccine Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:
Pneumococcal Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:
Pneumococcal Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
List of Pneumococcal Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pneumococcal vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pneumococcal vaccine companies profiled in this report include-
Pneumococcal Vaccine Market Insights
Lucintel forecasts that prevnar 13 is expected to witness highest growth over the forecast period due to its ability to protect children and adults from pneumococcal diseases caused by 13 serotypes of streptococcus pneumoniae.
Within this market, pneumococcal conjugate vaccine is expected to witness higher growth over the forecast period due to its capacity to prevent pneumococcal disease in children and young adults.
Features of the Global Pneumococcal Vaccine Market
Market Size Estimates: Pneumococcal vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Pneumococcal vaccine market size by product type, vaccine type, and region in terms of value ($B).
Regional Analysis: Pneumococcal vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product types, vaccine types, and regions for the pneumococcal vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pneumococcal vaccine market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q.1 What is the pneumococcal vaccine market size?
Answer: The global pneumococcal vaccine market is expected to reach an estimated $11.24 billion by 2030.
Q.2 What is the growth forecast for pneumococcal vaccine market?
Answer: The global pneumococcal vaccine market is expected to grow with a CAGR of 4.8% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the pneumococcal vaccine market?
Answer: The major drivers for this market are growing awareness of the importance of pneumococcal vaccination, development of new and innovative pneumococcal vaccines, and government initiatives to promote pneumococcal vaccination.
Q4. What are the major segments for pneumococcal vaccine market?
Answer: The future of the pneumococcal vaccine market looks promising with opportunities in the pneumococcal conjugate vaccine and pneumococcal polysaccharide vaccine markets.
Q5. Who are the key pneumococcal vaccine market companies?
Answer: Some of the key pneumococcal vaccine companies are as follows:
Q6. Which pneumococcal vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that prevnar 13 is expected to witness highest growth over the forecast period due to its ability to protect children and adults from pneumococcal diseases caused by 13 serotypes of streptococcus pneumoniae.
Q7. In pneumococcal vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to witness highest growth over the forecast period due to high prevalence of pneumococcal disease among population and presence of well-established healthcare system in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.